This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (37)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Walter G. Bradley, DM, FRCP; Reid Taylor, MD; David R. Rice, MD; Irena Hausmanowa-Petruzewicz, MD; Lester S. Adelman, MD; Margaret Jenkison, FIMLS, DMLM; Hanna Jedrzejowska, MD; H. Drac, MD; William W. Pendlebury, MD

Arch Neurol. 1990;47(9):1013-1017.

Abstract
• A progressive degenerative myopathy has been well described in hypokalemic periodic paralysis but is not as widely recognized in hyperkalemic periodic paralysis. We studied four families with the latter disease in which some members developed a progressive myopathy. Episodes of paralysis were prolonged, lasting for months in some cases, and in one case paralysis was sufficiently severe to require ventilatory support. The progressive myopathy tended to develop at a time when attacks of paralysis were decreasing in frequency. Muscle biopsy specimens showed variability in fiber size, internal nuclei, and fibers with vacuoles. Electron microscopy showed myofibrillary degeneration and tubular aggregates. An abnormal biopsy specimen was more common in older patients. Our experience suggests that a progressive myopathy is as common in hyperkalemic periodic paralysis as it is in the hypokalemic disorder.

Author Affiliations
From the Departments of Neurology and Neuropathology, Universities of Vermont, Burlington (Drs Bradley, Taylor, and Pendlebury), Warsaw (Poland) (Drs Hausmanowa-Petruzewicz, Jedrzejowska, and Drac), and Newcastle-Upon-Tyne (England) (Ms Jenkison), and Tufts-New England Medical Center, Boston, Mass (Drs Adelman and Rice). Dr Taylor is now with Mountain Neurological Center, PA, Asheville, NC; Dr Rice is now in private practice in Pomona, Calif.

Footnotes
Accepted for publication November 29, 1989.

Reprint requests to Department of Neurology, University of Vermont School of Medicine, Medical Center Hospital of Vermont, Brown 313, Burlington, VT 05405 (Dr Bradley).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
Matthews et al.
Brain 2009;0:awp294v1-awp294.
ABSTRACT | FULL TEXT  

The primary periodic paralyses: diagnosis, pathogenesis and treatment
Venance et al.
Brain 2006;129:8-17.
ABSTRACT | FULL TEXT  

Correlating phenotype and genotype in the periodic paralyses
Miller et al.
Neurology 2004;63:1647-1655.
ABSTRACT | FULL TEXT  

Tubular aggregate myopathy with abnormal pupils and skeletal deformities
Jacques et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:324-326.
ABSTRACT | FULL TEXT  

Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A
Sternberg et al.
Brain 2001;124:1091-1099.
ABSTRACT | FULL TEXT